These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Hong Y, Martin JF, Vainchenker W, Erusalimsky JD. Blood; 1996 Jan 01; 87(1):123-31. PubMed ID: 8547633 [Abstract] [Full Text] [Related]
7. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2. Dorsey JF, Cunnick JM, Mane SM, Wu J. Blood; 2002 Feb 15; 99(4):1388-97. PubMed ID: 11830491 [Abstract] [Full Text] [Related]
8. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells. Chang YI, Hua WK, Yao CL, Hwang SM, Hung YC, Kuan CJ, Leou JS, Lin WJ. J Biol Chem; 2010 Jul 02; 285(27):20595-606. PubMed ID: 20442406 [Abstract] [Full Text] [Related]
9. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Herrera R, Hubbell S, Decker S, Petruzzelli L. Exp Cell Res; 1998 Feb 01; 238(2):407-14. PubMed ID: 9473349 [Abstract] [Full Text] [Related]
10. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events. Shelly C, Petruzzelli L, Herrera R. Leukemia; 1998 Dec 01; 12(12):1951-61. PubMed ID: 9844925 [Abstract] [Full Text] [Related]
11. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation. Murray NR, Baumgardner GP, Burns DJ, Fields AP. J Biol Chem; 1993 Jul 25; 268(21):15847-53. PubMed ID: 8340409 [Abstract] [Full Text] [Related]
14. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Fichelson S, Freyssinier JM, Picard F, Fontenay-Roupie M, Guesnu M, Cherai M, Gisselbrecht S, Porteu F. Blood; 1999 Sep 01; 94(5):1601-13. PubMed ID: 10477685 [Abstract] [Full Text] [Related]
15. Sustained activation of MEK1-ERK1/2 pathway in membrane skeleton occurs dependently on cell adhesion in megakaryocytic differentiation. Mizutani C, Tohyama Y, Miura Y, Hishita T, Nishihara T, Yamamura H, Ichiyama S, Uchiyama T, Tohyama K. Biochem Biophys Res Commun; 2002 Sep 27; 297(3):664-71. PubMed ID: 12270146 [Abstract] [Full Text] [Related]
16. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. Melemed AS, Ryder JW, Vik TA. Blood; 1997 Nov 01; 90(9):3462-70. PubMed ID: 9345030 [Abstract] [Full Text] [Related]
17. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells. Kalina U, Koschmieder S, Hofmann WK, Wagner S, Kauschat D, Hoelzer D, Ottmann OG. Exp Hematol; 2001 May 01; 29(5):602-8. PubMed ID: 11376873 [Abstract] [Full Text] [Related]
18. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase. Thorburn J, Carlson M, Mansour SJ, Chien KR, Ahn NG, Thorburn A. Mol Biol Cell; 1995 Nov 01; 6(11):1479-90. PubMed ID: 8589450 [Abstract] [Full Text] [Related]
20. Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. Jiang F, Jia Y, Cohen I. Blood; 2002 May 15; 99(10):3579-84. PubMed ID: 11986211 [Abstract] [Full Text] [Related] Page: [Next] [New Search]